These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 11147309)
21. The impact of globalization on vaccine development and availability. Milstien JB; Kaddar M; Kieny MP Health Aff (Millwood); 2006; 25(4):1061-9. PubMed ID: 16835187 [TBL] [Abstract][Full Text] [Related]
22. Health sector reform: scourge or salvation for TB control in developing countries? Miller B Int J Tuberc Lung Dis; 2000 Jul; 4(7):593-4. PubMed ID: 10907759 [No Abstract] [Full Text] [Related]
23. Provinces providing more childhood vaccines. Eggertson L CMAJ; 2006 Jan; 174(1):20. PubMed ID: 16389226 [No Abstract] [Full Text] [Related]
24. How should GAVI build on its success? Arie S BMJ; 2011 Sep; 343():d5182. PubMed ID: 21903688 [No Abstract] [Full Text] [Related]
25. Vaccines, children, and fulfilling human potential. Dentzer S Health Aff (Millwood); 2011 Jun; 30(6):1006. PubMed ID: 21653949 [No Abstract] [Full Text] [Related]
26. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability? Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134 [TBL] [Abstract][Full Text] [Related]
27. [Denmark's global responsibility--the Danish development assistance policy]. Tørnaes U Ugeskr Laeger; 2006 Sep; 168(36):3004-6. PubMed ID: 16999888 [No Abstract] [Full Text] [Related]
28. GAVI and the Vaccine Fund--a boon for immunization in the developing world. Balaji KA Indian J Public Health; 2004; 48(2):45-8. PubMed ID: 15709583 [TBL] [Abstract][Full Text] [Related]
34. [Economic aspects of health care in relation to vaccination programs]. Kuszewski K Przegl Epidemiol; 2003; 57 Suppl 1():9-13. PubMed ID: 12920999 [No Abstract] [Full Text] [Related]
35. Policy analysis: an essential research tool for the introduction of vaccines in developing countries. Mahoney R J Health Popul Nutr; 2004 Sep; 22(3):331-7. PubMed ID: 15609786 [TBL] [Abstract][Full Text] [Related]
36. Apropos "New vaccines for developing countries: will it be feast or famine"? Arya SC; Agarwal N Am J Law Med; 2009; 35(4):691. PubMed ID: 20196288 [No Abstract] [Full Text] [Related]
37. Methodological issues and new developments in the economic evaluation of vaccines. Beutels P; Van Doorslaer E; Van Damme P; Hall J Expert Rev Vaccines; 2003 Oct; 2(5):649-60. PubMed ID: 14711326 [TBL] [Abstract][Full Text] [Related]
39. Requirements for high impact diagnostics in the developing world. Urdea M; Penny LA; Olmsted SS; Giovanni MY; Kaspar P; Shepherd A; Wilson P; Dahl CA; Buchsbaum S; Moeller G; Hay Burgess DC Nature; 2006 Nov; 444 Suppl 1():73-9. PubMed ID: 17159896 [No Abstract] [Full Text] [Related]
40. Polio eradication: 7 countries and US$ 210 million to go. Fleck F Bull World Health Organ; 2003; 81(9):696-7. PubMed ID: 14710517 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]